Condition: Heart Arrhythmia · Heart Diseases · Arrhythmias, Cardiac · Sponsor: Evangelical Hospital Düsseldorf
Ablation of consecutive atrial tachycardia (AT) after ablation of atrial fibrillation (AF) or cardiac surgery can be challenging due to complex substrate and AT mechanisms. A substantial portion of patients is known to show various tachycardias and recurrences occur in a noticeable number of cases. With the availability of novel ultra-high-density mapping techniques characterization and understanding of AT mechanisms and underlying substrate can be improved. Aim of this prospective, multi-center, randomized study is to compare a standard AT ablation approach versus minimalized ablation of the clinical AT in regards to arrhythmia free survival.
This description comes directly from the study's public registry record.
Christian Meyer, MD · 00492119191855 · christian.meyer@evk-duesseldorf.de
Always discuss trial participation with your own doctor first.
| Asklepios St. Georg | Hamburg, Free and Hanseatic City of Hamburg, Germany | Recruiting |
| Evangelic Hospital Düsseldorf | Düsseldorf, North Rhine-Westfalia, Germany | Recruiting |
| Vivantes Klinikum Am Urban Berlin | Berlin, Germany | Recruiting |
| Evangelic Hospital Hagen-Haspe | Hagen, Germany | Recruiting |
| Städtisches Klinikum Karlsruhe | Karlsruhe, Germany | Recruiting |
| Universitätsklinikum Schleswig Holstein | Kiel, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05239364